Publications

2009

iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.

Rajcevic U, Petersen K, Knol JC, Loos M, Bougnaud S, Klychnikov O, Li KW, Pham TV, Wang J, Miletic H, Peng Z, Bjerkvig R, Jimenez CR, Niclou SP. 2009 Nov. Mol Cell Proteomics.8(11):2595-612. Epub 2009 Aug 12.

Cancer stem cells and angiogenesis.

Bjerkvig R, Johansson M, Miletic H, Niclou SP. 2009 Oct. Semin Cancer Biol.19(5):279-84. Epub 2009 Oct 7.

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.

Miletic H, Niclou SP, Johansson M, Bjerkvig R. 2009 Apr. Expert Opin Ther Targets.13(4):455-68.

Treatment of neurodegenerative diseases (Parkinson's, Huntington's and Alzheimer's Diseases) with cell encapsulation technology. In The Bioartificial Pancreas and Other Biohybrid Therapies . (Book Chapter)

Utvik JK, Niclou SP. 2009 Jan. Hallé JP, De Vos P and Rosenberg L, eds. Kerala, India: Transworld Research Network, 2009. p.607-614. ISBN 978-81-7895-415-8.

Proteomics strategies for target identification and biomarker discovery in cancer.

Rajcevic U, Niclou SP, Jimenez CR. 2009 Jan. Front Biosci.14:3292-303.

Treatment of brain tumors with microencapsulated cell therapy. In The Bioartificial Pancreas and Other Biohybrid Therapies . (Book Chapter)

Niclou SP, Bjerkvig R. 2009 Jan. Hallé JP, De Vos P and Rosenberg L, eds. Kerala, India: Transworld Research Network, 2009. p.587-594. ISBN 978-81-7895-415-8.